These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 9829579

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ, Mikosch P, Kresnik E, Unterweger O, Gomez I, Lind P.
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
    Alam MS, Takeuchi R, Kasagi K, Misaki T, Miyamoto S, Iida Y, Hidaka A, Konishi J.
    Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF, Oei HY, Hennemann G, Krenning EP.
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.
    Ng DC, Sundram FX, Sin AE.
    J Nucl Med; 2000 Apr; 41(4):631-5. PubMed ID: 10768563
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation.
    Dadparvar S, Chevres A, Tulchinsky M, Krishna-Badrinath L, Khan AS, Slizofski WJ.
    Eur J Nucl Med; 1995 Nov; 22(11):1330-8. PubMed ID: 8575487
    [Abstract] [Full Text] [Related]

  • 12. Thallium-201 scintigraphy to predict therapeutic outcome of iodine-131 therapy of metastatic thyroid carcinoma.
    Nakada K, Katoh C, Kanegae K, Tsukamoto E, Shiga T, Mochizuki T, Itoh K, Tamaki N.
    J Nucl Med; 1998 May; 39(5):807-10. PubMed ID: 9591580
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Routine 201Tl scintigraphy in the follow-up of patients with differentiated thyroid carcinoma: diagnostic accuracy and clinical impact.
    Hsu CC, Chen YW, Huang YF, Chuang YW.
    Nucl Med Commun; 2007 Sep; 28(9):681-7. PubMed ID: 17667746
    [Abstract] [Full Text] [Related]

  • 16. Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma.
    Kosuda S, Yokoyama H, Katayama M, Yokokawa T, Kusano S, Yamamoto O.
    Eur J Nucl Med; 1995 Oct; 22(10):1218-20. PubMed ID: 8542909
    [Abstract] [Full Text] [Related]

  • 17. Disappointing results with Tc-99m tetrofosmin for detecting medullary thyroid carcinoma metastases comparison with Tc-99m VDMSA and TI-201.
    Adalet I, Demirkale P, Unal S, Oůz H, Alagöl F, Cantez S.
    Clin Nucl Med; 1999 Sep; 24(9):678-83. PubMed ID: 10478744
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relative value of thallium-201 and iodine-131 scans in the detection of recurrence or distant metastasis of well differentiated thyroid carcinoma.
    Lin JD, Kao PF, Weng HF, Lu WT, Huang MJ.
    Eur J Nucl Med; 1998 Jul; 25(7):695-700. PubMed ID: 9662590
    [Abstract] [Full Text] [Related]

  • 20. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery.
    Rubello D, Mazzarotto R, Casara D.
    Eur J Nucl Med; 2000 Apr; 27(4):431-40. PubMed ID: 10805117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.